Ranevetmab (NV-01) is a caninized monoclonal antibody targeting nerve growth factor (NGF). This antibody is specifically engineered for use in canine models to investigate and alleviate pain associated with degenerative joint disease (DJD). Ranevetmab binds selectively to NGF, a key mediator in the pathway of pain, thereby inhibiting its activity and providing a valuable tool for research into novel pain therapies in veterinary medicine.
Ranevetmab (NV-01) is a caninized monoclonal antibody targeting nerve growth factor (NGF). This antibody is specifically engineered for use in canine models to investigate and alleviate pain associated with degenerative joint disease (DJD). Ranevetmab binds selectively to NGF, a key mediator in the pathway of pain, thereby inhibiting its activity and providing a valuable tool for research into novel pain therapies in veterinary medicine.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
